Fludarabine Followed by Vaccine Therapy and White Blood Cell Infusions in Treating Patients With Unresectable or Metastatic Melanoma
Clinical trial NCT00091143 · COMPLETED
Trial details
- NCT number
- NCT00091143
- Sponsor
- Providence Cancer Center, Earle A. Chiles Research Institute
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2004-07-01
- Primary completion
- 2010-03-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.